Investment for First-in-Class Non-Opioid Analgesic NCE

Client

Milwaukee based pharmaceutical company focused on novel treatment for pain relief

Client Need

Investments and/or partnering to further develop their lead asset CMX-020.

Solution Approach

  • Aagami identified right investors/ partners, and took them to 50 + companies who are operating in Pain /CNS
  • Aagami brough 15+ companies had post CDA level scientific and clinical discussions. 
  • Aagami kept facilitating and persevering. several companies expressed interest to partner sooner or later.
  • Finally Aagami found an investor who transferred the first tranche in May 2023.
  • This enabled client to move one step further  in their development timeline. 
  • Aagami continues to look for further partnerships and investments for the client.

Results

  • Secured first Investment in April 2023
  • Enabled client to move to next steps in their development timeline. 
  • Further prospecting in Progress. Client is very happy and satisfied.


×
Twitter